source
- Axiom Biosciences targets Hong Kong IPO to raise up to $200 million for regenerative therapy pipelineAxiom Biosciences, a San Diego‑based biotech, announced plans to list on the Hong Kong Stock Exchange rather than the traditional U.S. exchanges. The company aims to use the offering to secure new…
- Dimension raises $800 million for third fund to boost AI-driven biotech venturesDimension, a venture capital firm focused on the intersection of technology and biotech, announced the closing of its largest fund to date, raising $800 million for its third fund, called Dimension…